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Abstract. Artichoke-like wild thistles are often used in 
Palestinian cuisine. One of the most commercially recognized 
species of these wild edible thistles is Gundelia tournefortii, 
a common plant in the Mediterranean region. G. tournefortii, 
or ‘Akoob’ in Arabic, remains uncultivated, harvested wild by 
local populations and considered highly valuable due to its 
reputed health benefits. The present study aimed to investigate 
the anticancer effects of G. tournefortii on the human colon 
carcinoma HCT-116 cell line. Methanol and hexane extracts 
were identified to exert considerable antitumor activity against 
the HCT-116 cancer cell line, while the aqueous extract was 
inactive. The phytochemical profiles of the methanol and hexane 
extracts were investigated using gas chromatography-mass 
spectrometry. A total of 6 of the 27 natural compounds identi-
fied, including sitosterol, stigmasterol, lupeol, gitoxigenin, 
α-amyrin and artemisinin, have been previously validated as 
being active against cancerous cells. Therefore, the presence 
of these phytochemicals in G. tournefortii is of importance in 
its role in preventing and treating cancer.
Introduction
Gundelia tournefortii (Asteraceae) thistle is a vegetable that 
is similar to artichoke and grows in the semi-desert climate 
of numerous countries in the Mediterranean region (1). 
Particularly in Palestine, G. tournefortii, or ‘Akoob’ in Arabic, 
remains uncultivated, harvested by local populations, and is 
considered highly valuable due to its reputed health benefits (2). 
Previously, it was listed as 1 of the 10 species with the highest 
mean cultural importance in northern Palestine (2), and it is 
a component of a number of traditional recipes, which differ 
according to different localities. In Palestinian traditional 
medicine and ethno-botany, this plant is believed to possess 
nutritive and curing benefits for diabetes, epilepsy, stomach and 
intestinal diseases (3,4). According to the literature, it has been 
validated to exert antioxidant, hepatoprotective and antibacterial 
effects (1,5). A previous study (2) conducted among Palestinians 
eating Akoob on a regular basis revealed a consensus belief of 
its capability to prevent and cure cancer. However, an intensive 
search of PubMed (using the terms gundelia tournefortii and 
cancer; on 12th September 2016) indicates that there is no single 
study on the effects of G. tournefortii extracts against cancer. 
The present study aimed to investigate the anticancer effects 
of G. tournefortii on the human colon cancer HCT-116 cell 
line. Gas chromatography-mass spectrometry (GC-MS) was 
utilized to explore the potential phytochemicals responsible for 
the anticancer activity. A total of 27 constituents were identi-
fied in G. tournefortii, of which 6 phytochemicals, including 
sitosterol, stigmasterol, lupeol, gitoxigenin, α-amyrin and arte-
misinin have been demonstrated to exhibit anticancer activities. 
To the best of our knowledge, the present study was the first 
to investigate the potential benefits of consuming wild edible 
G. tournefortii for cancer, and to analyze the phytochemical 
contents known for their anticancer effects.
Materials and methods
Plant material. The G. tournefortii plant was collected from 
the mountains of Nablus in northern Palestine between 
February and March 2014. The prickles were removed with 
scissors, and the stems and head sections (the parts of the plant 
that are usually consumed) were reserved. The processed plant 
was dried in the shade at room temperature.
Extract preparation. The air-dried aerial parts of G. tournefortii 
were ground into a fine powder using mixer grinder machine. 
Three equal fractions, weighing 25±0.01 g, of the ground plant 
were then transferred into Erlenmeyer flasks, and treated with 
250 ml methanol (MeOH of purity >99.9%), H2O or hexane 
(C6H14, 99% purity) solvents separately. The flasks were then 
sonicated for 2 h at 50˚C, and left in glass bottles (covered with 
aluminum foil) in the dark for 24 h to ensure complete extrac-
tion of the compounds. The extracts were filtered by passing the 
solvents through a 0.4‑µm filter. A total of 10 ml was removed 
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from each solvent type for analysis of antioxidant activity. The 
remaining volume from each solvent type was evaporated under 
reduced pressure (range, 0.05 and 0.2 atm) and dissolved in 
dimethyl sulfoxide for in vitro experiments. The yields of the 
extracts were calculated by dividing the weight of the extracted 
material following vacuum evaporation on the crude material 
and found to be 3.2, 1.8 and 12% (wt/wt) for the methanol, hexane 
and water extracts, respectively. The stock crude extracts were 
preserved in sealed glass containers and kept at ‑20˚C until use.
MTT assay. MTT is a water-soluble tetrazolium salt, which 
is converted to insoluble purple formazan by cleavage of 
the tetrazolium ring by succinate dehydrogenase within the 
mitochondria. The formazan product accumulates only in 
healthy cells. The assay was optimized for the cell lines used 
in the experiments. MTT was applied to assess cell viability as 
described in a previous study (6). HCT-116 (colorectal carci-
noma cell-line from the American Type Culture Collection 
termed in brief ATCC® CCL247™) cells (2x104/well) were 
plated in 200 µl medium/well in 96-well plates and were 
allowed to adhere to the plate for 24 h. The medium was 
purchased from Biological Industries Israel Beit Haemek Ltd, 
Kibbutz Beit Haemek, Israel. Plant extracts were added at 
increasing concentrations (0-1,000 µg/ml) for 22 h. The cell 
medium was then replaced with 100 µl fresh medium/well 
containing 0.5 mg/ml MTT and cultivated with the cells for an 
additional 4 h in an incubator in the dark at 38˚C. The super-
natant was removed and 100 µl isopropanol/HCl [2% HCl 
(0.1 M) in isopropanol] was added to each well. The absor-
bance at 620 nm (A620) was measured with microtiter plate 
reader (Anthos Labtec Instruments, Austria). For each plate, 
two wells without cells served as blanks. All experiments 
were repeated three times in triplicate. The effects of the plant 
extracts on cell viability were expressed using the following 
formula: Percent viability = (A620 of treated sample / A620 of 
non-treated sample) x100.
GC‑MS analysis. Solutions of the G. tournefortii methanol 
and hexane extracts were selected and examined with GC-MS 
using an Agilent 7890A GC system coupled with the Agilent 
5975C inert MSD with Triple-Axis Detector mass spectrometer 
(Agilent Technologies, Inc., Santa Clara, CA, USA). The GC 
was performed on an Agilent J&W GC HP-5 column [30 m x 
0.32 mm (inner diameter), with 0.25‑µm film thickness; Agilent 
Technologies, Inc., Santa Clara, CA, USA]. The carrier gas was 
helium at a flow rate of 1.2 ml/min, and the injection volume 
was 1 µl. The injection port and the MS interface temperatures 
were 300˚C and the ionization voltage was 70 eV. The samples 
were injected in the split mode with a ratio of 10:1. Mass 
spectra were recorded every second over a range set at (m/z) of 
45-800 Da. The oven heating stage was activated with an initial 
temperature of 50˚C for 5 min, then increased to 320˚C at a 
rate of 5˚C/min, and then maintained at 320˚C for an additional 
20 min. The total duration of the GC-MS protocol was 79 min, 
and the solvent delay time was 7 min.
The percentages of the phytochemical components were 
computed from the GC peak areas normalization. The normal-
ization is done automatically by the software while dividing 
the peak area of each peak by the total area and multiply by 
100. Library searches were performed using the Mass Spectral 
Library of the National Institute of Standards and Technology 
(Gaithersburg, MD, USA).
Results and Discussion
In vitro anticancer activity of the different G. tournefortii 
extracts. The effects of G. tournefortii extracts on HCT-116 
Figure 1. Total ion chromatogram of Gundelia tournefortii hexane extract.
Figure 2. Total ion chromatogram of Gundelia tournefortii methanol extract.
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human colon cancer cells were determined using the MTT 
assay. The HCT-116 cell line was exposed to G. tournefortii 
methanol, hexane and aqueous extracts (0-1,000 µg/ml for 
22 h. The half maximal effective concentrations obtained 
by the MTT assay were 303.3±12 µg/ml for the methanol 
extract and 313.3±18.6 µg/ml for the hexane extract. However, 
the aqueous extract only reduced cell viability to 74.8% at 
concentration of 1,000 µg/ml, thus demonstrating inactivity 
on cancer cells.
Phytochemical analysis of G. tournefortii using GC‑MS. 
The phytochemical screening using GC-MS in the electron 
impact mode revealed 27 compounds in the G. tournefortii 
methanol and hexane extracts, 19 of which, to the best of our 
knowledge, were detected for the first time in G. tournefortii 
(Figs. 1-4), with the remaining 6 components [including stig-
masterol (PubChem CID: 5280794), β-sitosterol (PubChem 
CID: 222284), palmitic acid, linoleic acid, α-linolenic acid and 
stearic acid] having been identified previously (5). Figs. 1 and 2 
indicate the total ion chromatograms of the hexane and meth-
anol extracts. The analysis of these two extracts revealed 14 
and 13 major components in the hexane and methanol extracts, 
respectively (Tables I and II; Figs. 3 and 4). Compounds such as 
sterols, triterpenes, esters and carboxylic acids were observed 
in the G. tournefortii extracts in large quantities. For example, 
two common sterols known as sitosterol and stigmasterol 
(Fig. 3), were observed in the hexane extract constituting ~10% 
of its components (Table I). It has been demonstrated that 
sitosterol acts as an inhibitor of tumor promotion in vivo and 
that it inhibits carcinogenesis (7,8). Furthermore, stigmasterol 
significantly inhibits tumor promotion in two‑stage carcino-
genesis in mice (7,9). A mixture of sitosterol and stigmasterol 
was indicated to possess anti‑inflammatory activity following 
topical application (10). Therefore, it is expected that the pres-
ence of such sterols in G. tournefortii may be important for its 
anticancer activities.
Lupeol (PubChem CID: 222284; Table I; Fig. 3), an addi-
tional phytochemical, which to the best of our knowledge has 
never been identified to be present in G. tournefortii, weighed 
~10% of the hexane extract. It has been revealed to act as a 
novel androgen receptor, which inhibits the proliferation of 
human prostate cancer cells by targeting β-catenin signaling 
during carcinogenesis (11).
Table I. Phytochemicals of Gundelia tournefortii from the hexane extract by gas chromatography-mass spectrometry.
No. Retention time (mins) Component name Abundance, %
  1 35.91 Methyl palmitate 1.89
  2 38.94 Methyl linoleate 1.27
  3 39.06 Ethyl oleate 1.65
  4 50.39 NI 1.96
  5 53.01 Heptadecane 4.21
  6 54.69 Stigmasterola 5.75
  7 55.44 β-sitosterola 5.09
  8 55.89 α-amyrina 5.76
  9 56.45 Lupeola 9.17
10 56.95 Olean-12-en-3-yl acetate 9.58
11 57.49 Thunbergol 24.41
12 57.59 Hop-22(29)-en-3.β.-ol 11.31
13 58.45 NI 6.58
14 58.58 A'-neogammacer-22(29)-en-3-ol, acetate, (3.β.,21.β.)- 8.341
NI, not identified. aAnticancer component.
Figure 3. Chemical structure of the major components in Gundelia tournefortii 
hexane extract.
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In addition to the aforementioned 4 anticancer 
phytochemicals, gitoxigenin (PubChem CID: 348482; 
Table II), which weighed ~1.5% of the G. tournefortii 
methanol extract, was suggested to elicit significant anticancer 
activity (12) against renal adenocarcinoma and other cancer 
cell lines, with half-maximal inhibitory concentration (IC50) 
values in the µM range. Furthermore, α-amyrin (PubChem 
CID: 73170; Table I; Fig. 3), which composed ~5.7% of the 
hexane extract, was identified previously to have significant 
anticancer activity (13) on four cancer cell lines (MCF-7, 
BEL-7402, SPC-A-1 and SGC-7901), with IC50 values of 
7.2±0.12, 8.2±0.29, 7.6±0.06 and 5.0±0.12 µM, respectively.
The methanol extract contained 6 carboxylic acids, 
together representing almost half of the whole extract (48.9%). 
Artemisinin (PubChem CID: 68827; Table II), an active 
promising photochemical, was also identified for the first 
time, to the best of our knowledge, in G. tournefortii extracts, 
comprising 2.39%. This compound is currently undergoing 
investigation for its use in the treatment of cancer (14). 
Additionally, artemisinin was mentioned in >300 studies as 
a compound with potential anticancer activities (PUBMED 
search using the terms: Artemisinin AND [anticancer OR 
cytotoxic], on 21 September 2016).
Summary. To the best of our knowledge, the present study was 
the first to highlight the anticancer activity of G. tournefortii. 
Methanol and hexane extracts exhibited anticancer capacities 
against the HCT-116 cancer cell line, while the aqueous extract 
was inactive. Using GC-MS, miscellaneous phytochemicals in 
the methanol and hexane extracts were identified. The results 
Table II. Phytochemicals of Gundelia tournefortii from the methanol extract by gas chromatography-mass spectrometry. 
No. Retention time, min Component name Abundance, %
  1 26.72 Dodecanoic acid 5.16
  2 31.16 Tetradecanoic acid 1.58
  3 32.89 6,10,14-trimethylpentadecan-2-one 1.18
  4 34.82 (Z)-11-hexadecenoic acid 2.41
  5 35.25 Palmitic acid 11.70
  6 38.45 Linoleic acid 26.88
  7 38.57 (9Z)-9,17-octadecadienal 39.28
  8 42.38 Artemisinina 2.39
  9 42.62 Matricarin 1.97
10 56.44 Hop-22(29)-en-3.β.-ol 2.81
11 57.48 NI 1.53
12 57.58 NI 1.59
13 58.22 Gitoxigenina 1.51
NI, not identified. aAnticancer component.
Figure 4. Chemical structure of major components in Gundelia tournefortii 
methanol extract.
Figure 5. Chemical structures of 6 of the 27 phytochemicals validated 
as being active against cancerous cells: Sitosterol, stigmasterol, lupeol, 
gitoxigenin, α-amyrin, and artemisinin.
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obtained indicate the abundance of important active ingredients 
in this plant. The existence of potent chemicals, such as sitosterol, 
stigmasterol, lupeol, gitoxigenin, α-amyrin and artemisinin 
(Fig. 5) may act additively or synergistically, and therefore 
would be important factors in the preventative and anticancer 
properties of G. tournefortii. The results of the present study 
are in concordance with the survey conducted on participants 
who regularly consumed Akoob, with the belief that it possesses 
anticancer benefits (2). Additional studies aiming to identify the 
mechanism of action, and to evaluate the efficacy and toxicity of 
G. tournefortii in in vivo models, are required.
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